A GLP 14-Day Repeat Dose Toxicology Study of SPR206 in Monkeys Posted on June 21, 2019 at 3:21 pm.Written by Spero Therapeutics View Presentation Post navigation In Vivo Efficacy of Next-Generation Polymyxin SPR206 in an Immunocompetent Murine Ascending UTI Infection Model Caused by Escherichia coliTebipenem: Oral Carbapenem for the Treatment of Complicated Urinary Tract Infections – Oral Presentation
